Physician

Jacqueline Denise Milam, MD

According to 2025 Medicare claims, Jacqueline Milam, MD (NPI: 1972584993) practices internal medicine in the Clarksville, TN-KY market, with the plurality of this provider's patient population coming from Montgomery, TN. This provider's primary affiliated billing organization is PREMIER MEDICAL GROUP PC (NPI: 1740242957; TIN: 621586159) and primary practice location at 37040-5007. Milam is affiliated with the CHSPSC ACO 15, LLC (ACO ID: A3692), participating under the MSSP model.

Milam's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,437 traditional Medicare patients, billed 8,848 HCPCS/CPT codes, and received $197,210 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 7,455 prescription claims across 519 beneficiaries totaling $441,630 in drug costs, led by Ozempic (Semaglutide). DME data shows 278 claims. Open Payments data shows 6 records totaling $26,152. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $75,856 to $197,210. Similarly, Part D prescription costs have risen steadily, from $118,305 to $441,630. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $9,132 and ending at $14,060.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	428	2,853	$75,856
2016	2,254	9,026	$167,615
2017	3,037	10,304	$176,466
2018	2,991	9,923	$172,065
2019	3,082	10,310	$176,673
2020	2,718	9,159	$156,973
2021	2,266	8,784	$187,362
2022	2,154	7,833	$180,719
2023	2,028	7,142	$175,668
2024	2,437	8,848	$197,210

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	252	1,859	$118,305
2016	307	4,857	$283,937
2017	329	5,740	$295,746
2018	355	6,076	$346,727
2019	356	6,297	$347,950
2020	376	6,348	$349,758
2021	402	6,233	$399,298
2022	408	6,456	$416,821
2023	455	6,748	$442,378
2024	519	7,455	$441,630

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	22	203	$5,723
2016	38	265	$11,583
2017	31	274	$9,983
2018	65	397	$12,479
2019	42	237	$8,248
2020	60	349	$11,765
2021	46	231	$8,432
2022	27	328	$16,452
2023	29	224	$8,090
2024	26	278	$14,203

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	341	710	$76
80053	Blood test, comprehensive group of blood chemicals	310	425	$10
36415	Insertion of needle into vein for collection of blood sample	357	717	$9
85027	Complete blood cell count (red cells, white blood cell, platelets), automated test	307	402	$6
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	2,030	3,224	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ozempic	Semaglutide	46	1,442	$44,111
Eliquis	Apixaban	40	2,170	$39,957
Jardiance	Empagliflozin	48	2,100	$37,931
Januvia	Sitagliptin Phosphate	46	1,983	$37,589
Trulicity	Dulaglutide	32	1,064	$35,929

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	N/R	11	$3,897
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	31	$2,154
A5061	Ostomy pouch, drainable; with barrier attached, (1 piece), each	N	N/R	11	$1,247
A4385	Ostomy skin barrier, solid 4 x 4 or equivalent, extended wear, without built-in convexity, each	N	N/R	11	$1,199
A7033	Pillow for use on nasal cannula type interface, replacement only, pair	N	N/R	14	$961

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	0	$0	N/R
Research Payments	Reported research-related payment or transfer-of-value amount.	6	$26,152	Madrigal Pharmaceuticals
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jacqueline Denise Milam, MD?

Tedicare shows public-source Medicare data for Jacqueline Denise Milam, MD (NPI 1972584993), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jacqueline Denise Milam, MD have ACO affiliation data?

Jacqueline Denise Milam, MD is shown with ACO affiliation data for CHSPSC ACO 15, LLC (MSSP, ACO ID A3692).

What billing organization is linked to Jacqueline Denise Milam, MD?

Jacqueline Denise Milam, MD is linked to PREMIER MEDICAL GROUP PC (billing NPI 1740242957) in the available physician profile data.

Does Jacqueline Denise Milam, MD have Open Payments data?

Jacqueline Denise Milam, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.